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Aim: The effect of orexin on wakefulness has been shown to be largely mediated by 
activation of histaminergic neurons via orexin receptor-2 (OX2R). Consistently, OX2R mRNA 
is abundantly expressed in histaminergic neurons in the tuberomammillary nucleus (TMN). 
However, orexin receptors in the other regions of the brain might also play important roles in 
maintenance of wakefulness. To dissect the role of histaminergic system as downstream 
mediator of orexin system in regulation of sleep/wake states without compensation by the 
OX1R-mediated pathway, we analyzed phenotype of H1R-/-;OX1R-/- mice. This mice lack 
OX1R-mediated regulation of noradrenergic neurons in the locus coeruleus and either H1R 
system belonging to downstream of OX2R in the TMN. By analyzing H1R-/-;OX1R-/- mice, we 
aimed to find out the function of OX2R–mediated pathways other than histaminergic system 
in the TMN in sleep/wake regulation. 
Methods: We used H1R-/-;OX1R-/- mice, H1R-/- mice, and their littermate wild type mice. REM 
sleep, NREM sleep, and awake states were determined by polygraphic 
electroencephalographic/electromyographic (EEG/EMG) recording.  
Results: We did not observe detectable abnormality in sleep/wake states of H1R-/- mice, 
consistent with previous studies. H1R-/-;OX1R-/- mice also showed comparable sleep/wake 
phenotype as wild type mice. This result indicates that regulation of sleep/wake system is 
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completely achieved by OX2R-expressing neurons without involving H1R-mediated 
pathways.  
Conclusion: Our observation showed that the maintenance of basal physiological 
sleep/wake states is fully achieved without both H1 and OX1 receptors. Downstream 
pathways of OX2R other than histaminergic system might play an important role in 




The neuropeptides orexin A and orexin B (hypocretin 1 and hypocretin 2) are found 
as endogenous ligands for two orphan G-protein coupled receptors (Sakurai et al., 1998). 
There are two receptor subtypes, named orexin receptor-1 (OX1R) and orexin receptor-2 
(OX2R). Orexin-producing neurons, localized in the lateral hypothalamic area (LHA), send 
projections to all over the central nervous system except the cellebellum. Especially dense 
orexin-immunoreactive fibers were found in monoaminergic and cholinergic nuclei in the 
brain stem regions (Marcus et al., 2001). Moreover, these nuclei abundantly express orexin 
receptors. Recent studies on efferent and afferent systems of orexin neurons, and 
phenotypic characterization of genetically modified mice in the orexin system have 
suggested roles of orexin system in regulation of sleep and wakefulness through 
interactions with systems that regulate emotion, reward system and energy homeostasis 
(Boutrel et al., 2005), (Sakurai et al., 2005), (Yamanaka et al., 2003), (Yoshida et al., 2006), 
(Mieda et al., 2004), (Narita et al., 2006), (Harris et al., 2005), (Akiyama et al., 2004).  
Mice with targeted deletion of the prepro-orexin gene display a phenotype strikingly 
similar to human narcolepsy (Chemelli et al., 1999). Besides, functionally-null mutations in 
the OX2R gene were found in familial narcoleptic dogs (Lin et al., 1999). Consistently, 
OX2R-/- mice show fragmented sleep/wake behavior and direct transitions from wakefulness 
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to REM sleep, although phenotype is significantly milder than that of orexin-/- mice, whereas 
OX1R-/- mice do not have any overt behavioral abnormalities (Willie et al., 2001). Narcoleptic 
human brains have been shown to be associated with markedly reduced numbers of orexin 
neurons (Nishino et al., 2000), (Peyron et al., 2000), (Thannickal et al., 2000). These 
observations suggest that the OX2R-mediated pathway has pivotal roles, although OX1R 
has an additional role in the regulation of sleep/wake states.  
Orexin receptors are distributed in a pattern consistent with orexin projections. 
mRNAs for OX1R and OX2R were differentially expressed throughout the brain (Marcus et 
al., 2001). OX1R is most abundantly expressed in the locus cerules (LC), whereas OX2R is 
most abundantly expressed in the tubaromamillary nucleus (TMN). The raphe nuclei contain 
both receptors mRNA. In vitro electrophysiological studies have also showed that all these 
monoaminergic neurons are activated by orexins. These monoaminergic neurons are 
implicated in regulation of sleep/wake states (Hara et al., 2001), (Lin et al., 1999), (Peyron et 
al., 2000), (Thannickal et al., 2000), (Chemelli et al., 1999). 
Several studies showed that the arousal effect of orexin A largely depends on the 
activation of the histaminergic neurotransmission mediated by the histamine receptor-1 
(H1R) (Huang et al., 2001). Furthermore, histamine concentrations in the brain were 
decreased in OX2R mutated narcoleptic dogs (Lin et al., 1999). These observations have 
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suggested the importance of interaction between orexin system and the TMN histaminergic 
system in regulation of sleep/wake states. 
Histaminergic neurons are exclusively localized in the TMN (Watanabe T, 1984), 
and practically project to all brain regions with especially dense innervations in the 
hypothalamus, basal forebrain and amygdala (Panula P, 1984), (Takeda N, 1984). Those 
neurons are large and have a multi-dendritic shape and contain histidine decarbosylase 
(HDC), which converts L-histidine to histamine. The central histaminergic system is involved 
in many important function of the central nervous system, such as regulation of food intake 
(Morimoto T, 2001), thermoregulation and sleep/wake regulation (Lin JS, 1988), 
(Vanni-Mercier G, 1984) . It has been reported that the firing rates of histamine neurons vary 
across the sleep/wake cycle (Sakai, 1990), and intracerebroventricular (i.c.v.) injection of 
histamine or H1 agonist induces wakefulness and diminution of non-rapid eye movement 
(NREM) sleep (Monti JM, 1986), (Tasaka K, 1989), (Monti, 1993). These results suggest 
that the brain histaminergic system plays a critical role in regulation of sleep/wake states. 
Orexin neurons densely innervate TMN neurons, where OX2R is abundantly 
expressed (Marcus et al., 2001), further suggesting the possibility that orexin neurons 
regulate vigilance and arousal through modulating the activity of histaminergic neurons in 
the TMN. However, H1R-deficient mice show normal sleep/wake phenotype. This 
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contradicts the hypothesis that histaminergic system the most important as the downstream 
systems of the OX2R. A possible explanation of this discrepancy is the compensation by 
other systems such as noradrenergic neurons in the LC, serotonergic neurons in the raphe, 
and cholinergic neurons in the LDT/PPT. OX2R-/- mice are affected with cataplexy like 
attacks of REM sleep and sleep/wake fragmentation(Willie et al., 2003), suggesting that solo 
deficiency of  OX2R-signaling pathway can affect stability of sleep/wake states. On the 
otherhand, single OX1R-deficiency might be compensated by OX2R-mediated pathways. 
These observations suggest that solo deficiency of OX2R might be also compensated by 
OX1R-mediated pathway, because the phenotype of OX2R-deficient mice is milder than 
prepro-orexin knockout mice. 
In the present study, we analyzed the role of histaminergic system as a 
downstream signaling of OX2R-mediated pathway using H1R and OX1R double deficient 
mice (H1R-/-;OX1R-/-). In these mice, OX1R-mediated pathway was totally abolished, while 
OX2R-mediated pathway remained intact, but H1R-mediated pathway is deficient system. 
Therefore, these mice enable us to analyze the roles of the H1R-mediated pathway without 
compensation by OX1R-mediated pathways.  
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Materials and Methods 
Animal preparation 
All experimental procedures involving animals were approved and conducted in 
accordance with the University of Tsukuba and Kanazawa University Animal Care 
Committees. All efforts were made to minimize animal suffering from discomfort and to 
reduce the number of animals used. H1R-/- mice were previously reported in detail (Inoue I, 
1996). OX1R/- and OX2R/- mice were described previously (Hara et al., 2001, Willie et al., 
2003). Mice were housed under controlled lighting (12 hr light-dark cycle; light-on at 8:00 
a.m., off at 8:00 p.m.) and temperature conditions. Food and water were available ad 
libitum.  
All mice were backcrossed with C57BL/6J mice more than 6 times.  
 
Surgery 
Male mice (10-12 weeks old, 20-25 g at the time of surgery) were prepared for 
chronic monitoring of EEG/EMG signals using a lightweight implant and cabling procedure. 
Full details of this technique were published previously (Chemelli et al., 1999). Briefly, the 
EEG/EMG implant was based on a six-pin double inline microcomputer connector, modified 
to form four EEG electrodes, each 1.3 mm x 0.3 mm (h x w) positioned 4.6 mm x 2.9 mm (l x 
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w) apart with two EMG electrodes soldered to the enter pins. Mice were anesthetized with 
sodium pentobarbital (Nembutal, 50-60 mg/kg i.p.), and standard sterile surgical and 
stereotaxic procedures were employed for implant placement. Four burr holes were drilled 
on the cranium, anterior and posterior to bregma, bilaterally (AP 1.1, ML 1.4 and AP-3.6, 
ML1.4) according to the atlas of Franklin and Paxinos (1997). The implant was then inserted 
into these holes, fixed to the skull with adhesive dental cement, and the EMG electrodes 
were placed into the nuchal musculature, and wounds were closed by sutures. 
 
Electrophysiological recording 
Immediately after surgery, mice were housed singly for a recovery period of a week. 
The head-mounted connector was coupled via a light weight cable to a slip ring commutator, 
which was suspended from a counter-balanced arm mounted to a standard shoebox cage 
(19 cm x 30 cm, Allentown Caging, Allentown, NJ). This allowed mice full freedom of 
movement. The cage was modified to provide side delivery of food and water that were 
available ad libitum. All mice were habituated to these conditions for at least 7 days before 
recording was begun. Then EEG/EMG recording for two consecutive 24 hr period, 
beginning at lights-on at 8:00 pm was performed. Infrared video recording was 
simultaneously performed. EEG/EMG signals were amplified using a multichannel amplifier 
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(Nihon Koden, Tokyo, Japan) and filtered (EEG: 0.5-100 Hz, EMG: 0.5-100 Hz) before being 
digitized at a sampling rate of 250 Hz, displayed on a paperless polygraph system, and 
archived for off-line sleep staging and analysis.  
 
Sleep scoring and data analysis  
EEG/EMG records were visually scored into 16 s epochs of Awake, REM sleep, 
and NREM sleep. Data were analyzed by two-way ANOVA followed by post hoc analysis of 
significance with the Bonferroni’s or Student’s t test using the Stat View 5.0 software 





Sleep/Wake States Characteristics 
 Sleep state patterns of H1R-/-;OX1R-/- mice, H1R-/- mice, and wild type mice were 
revealed by simultaneous EEG/EMG recording as previously reported(Chemelli et al., 1999). 
Typical representative 12 hour dark period (20:00-8:00) hypnograms for H1R-/- mice and 
H1R-/-;OX1R-/- mice are shown in Figure 1. Under baseline conditions, the patterns of 
sleep/wake states were statistically not different among wild type, H1R-/- mice, OX1R-/- mice, 
H1R-/- mice, and H1R-/-;OX1R-/- mice. There were no significant differences between 
H1R-/-;OX1R-/- mice, H1R-/- mice, and their littermate wild type mice, in either the amounts 
and duration of NREM sleep, REM sleep and wakefulness during dark period(Figure 2).  
These parameters were not distinguishable among all genotypes during light period (table 1). 
Hourly analysis of quantities of NREM sleep, REM sleep and wakefulness also revealed that 
there are no detectable differences between control, H1R-/- and H1R-/-;OX1R-/- mice (Figure 
3). In contrast, OX1R-/-;OX2R-/- mice show significantly shorter duration of wakefulness and 
direct transitions from wakefulness to REM sleep as previously described (Hara et al., 






 The actions of orexins are mediated via two G-protein coupled receptors, OX1R 
and OX2R. Although these orexin receptors are expressed in a pattern consistent with orexin 
projections, mRNAs for OX1R and OX2R were differentially distributed in the brain. Several 
studies have indicated that the effect of orexin is largely mediated by activation of the 
histaminergic system through the OX2R in the TMN (Huang et al., 2001), (Shigemoto Y, 
2004), (Yamanaka A, 2002) . Consistently, OX1R-/- mice showed normal sleep/wake 
phenotype, while OX2R-/- mice are affected with cataplexy like attacks of REM sleep and 
sleep/wake fragmentation (Willie et al., 2001),  (Sakurai, 2007). However, phenotype of 
OX2R-/- mice was significantly milder than OX1R-/-;OX2R-/- mice (Sakurai, 2007). From these 
observations, loss of OX1R has additional effects on sleep/wake states, although chronic 
loss of OX1R in mice might be fully compensated by OX2R function.
From these observations, the histaminergic pathway is currently thought to be the 
most important pathway in the OX2R-pathway in arousal regulation. 
Three distinct subtypes of histamine receptors, H1 receptor (H1R), H2 receptor 
(H2R), and H3 receptor (H3R) are distributed in the brain and exhibit well defined distribution 
patterns (Bouthenet ML, 1988), (Martinez-Mir MI, 1990) . H1R and H2R are postsynaptic 
receptors coupled to Gq/11 and Gs protein, and H3R is a presynaptic autoreceptor coupled to 
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Gi/o protein. Previous pharmacological studies demonstrated that clinical use of H1R 
antagonists promotes sleepiness (Nicholson AN, 1985). The depletion of endogenous 
histamine by injection of α-fluoromethylhistidine, an HDC inhibitor, decreased the amount of 
nocturnal wakefulness in rats (Kiyono S, 1985) . Also, slow-wave sleep is induced in cats by 
microinjections of the selective H1R antagonist pyrilamine into the preoptic area (Lin JS, 
1994)  or the dorsal pontine tegmentum (Lin JS, 1996) . These results suggest that H1R 
mediates the waking effect of histamine.  
However, Huang et al. reported that H1R-/- mice showed sleep/wake states 
essentially identical to those of wild type mice but with fewer incidents of brief awakening 
(<16-sec epoch), and prolonged durations of non-rapid eye movement (NREM) sleep 
episodes, although the physiological significance of brief awakening has not been well 
understood yet (Huang ZL, 2006) . This suggests that the physiological function of H1R does 
not contribute in regulating the basal amount of sleep/wake states. Alternatively, chronic 
deficiency of H1R-mediated pathways is compensated by other arousal-related pathways 
such as noradrenergic system in the LC, in which OX1R is abundantly expressed.  
 In this study, we analyzed H1R-/-;OX1R-/- mice to define importance of the role of 
histaminargic system as a downstream effector of the orexinergic system in sleep/wake 
regulation. This mice lack both OX1R-mediated regulation of noradrenergic neuron in the 
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locus coeruleus (LC), and H1R system belonging to downstream of OX2R in the TMN. 
Signaling pathways in the downstream of OX2R, such as serotonergic neuron in the raphe  
nuclei, cholinergic neuron in the LDT/PPT, dopaminergic neuron in the VTA remain intact. 
The raphe nuclei, LDT/PPT, and VTA also abundantly express OX1R in wild type mice, but in 
H1R-/-;OX1R-/- mice, only OX2R is expressed in these regions. By analyzing these mice, we 
analyzed the role of H1R system belonging to downstream of OX2R. We found that 
H1R-/-;OX1R-/-  mice showed normal sleep/wake phenotype as compared with wild type mice. 
These results are not consistent with the hypothesis that “activation of the histaminergic 
system via OX2R is the most important pathway in sleep/wake regulation”. In consistent with 
these results, Blanco-Centurion et al. reported that saporin-induced lesions in the TMN of 
the histamine neurons, along with the cholinergic neurons in the basal forebrain (BF), and 
the noradrenergic neurons in the locus ceruleus (LC) did not change waking amount, 
although the lesions effected the transition time of light-dark phase (Blanco-Centurion C, 
2007). Our observations suggest that the regulations of basal physiological sleep/wake 
states are fully achieved without H1R even when OX1R is absent. Loss of H1R-mediated 
pathway might be fully compensated by OX2R-mediated pathways without contribution of 
OX1R. Considering that fact that OX2R-/- show mild but definite narcoleptic phenotype, 
OX2R-mediated pathways other than histaminergic pathways might highly important for 
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basal regulation of sleep/wake states.  
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Legends to figures 
Figure 1. Representative 12hr dark period (20:00-8:00) hypnograms for wild type (WT), 
H1R-/- , H1R-/-;OX1R-/- and OX1R-/-;OX2R-/- mice. The height of the horizontal line above 
baseline indicates the vigilance state of the mouse at the time. W, wakefulness; NR, 
non-REM sleep; R, REM sleep. There were no significant sleep/wake abnormalities 
between them. Hypnograms were obtained by simultaneous EEG/EMG recording. 
 
Figure 2. (A) Total time (minutes, mean±SEM) spent in each state (awake, non-REM sleep, 
and REM sleep) in H1R-/-, H1R-/-;OX1R-/- and wild type mice during dark period. (B) Episode 
duration (seconds±SEM) spent in each state (awake, non-REM sleep, and REM sleep) 
during dark period in H1R-/-, H1R-/-;OX1R-/-, wild type mice, and OX1R-/-;OX2R-/- mice. 
OX1R-/-;OX2R-/- mice show  characteristic of narcoleptic disorder induced by deficiency of 
both orexin receptors. However mice with other genotypes did not show abnormality in 
sleep/wake states. The bar graphs summarize the data during the 12h dark period.  
*p<0.001 (statistical analyses) 
 
Figure 3. Hourly analysis of sleep/wake amounts in control, H1R-/-, H1R-/-;OX1R-/-, and 
OX1R-/-;OX2R-/- mice. The shaded area represent the 12h dark cycle. There are no 
23 
 
significant differences between H1R-/-;OX1R-/- mice, H1R-/- mice, and their littermate wild type 
mice, while OX1R-/-;OX2R-/- mice show abnormal circadian distribution of REM sleep. 
 
 
Table 1. Total time spent in each state (minutes, mean ± SEM), episode duration (seconds ± 
SEM), REM latency (minutes, mean ± SEM) over 24 hr and itemized separately for light and dark 
periods. There are no significant differences between H1R-/-;OX1R-/- mice, H1R-/- mice, and their 
littermate wild type mice. *p<0.05 (statistical analyses)  




